β 2-Glycoprotein I inhibits endothelial cell migration through the nuclear factor κB signalling pathway and endothelial nitric oxide synthase activation

Biochemical Journal

Volumn 445, Issue 1, 2012, Pages 125-133

  Chiu, Wen Chin ^a   Chiou, Tzeon Jye ^b   Chiang, An Na ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

2 glycoprotein I ( 2 GPI); Endothelial cell migration; Endothelial nitric oxide synthase (eNOS); Nitric oxide (NO); Nuclear factor B (NF B)

Indexed keywords

BETA2 GLYCOPROTEIN 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; NEUTRALIZING ANTIBODY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN P50; SMALL INTERFERING RNA; SYNAPTOTAGMIN I;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; WOUND HEALING;

AORTA; BETA 2-GLYCOPROTEIN I; BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; HUMANS; I-KAPPA B PROTEINS; NF-KAPPA B P50 SUBUNIT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; WOUND HEALING;

EID: 84862493802     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20111383     Document Type: Article

References (50)

1. 2 glycoprotein I: function in health and disease. Thromb. Res. 114, 335-346
2. 2-glycoprotein I deficiency. Blood 96, 1594-1595
3. 2-glycoprotein I deficiency: prevalence, genetic background and effects on plasma lipoprotein metabolism and hemostasis. Atherosclerosis 152, 337-346
4. 2-GPI promoter activity. Biochem. J. 380, 455-463
5. 2-glycoprotein I gene expression in hepatoma cells. J. Cell. Biochem. 111, 988-998
6. Hulsmans, M. and Holvoet, P. (2010) The vicious circle between oxidative stress and inflammation in atherosclerosis. J. Cell. Mol. Med. 14, 70-78
7. 2-glycoprotein I. J. Immunol. 185, 1550-1557
8. 2-glycoprotein I to human endothelial cells is mediated by annexin II. J. Biol. Chem. 275, 15541-15548
9. Tabruyn, S. P., Colton, K., Morisada, T., Fuxe, J., Wiegand, S. J., Thurston, G., Coyle, A. J., Connor, J. and McDonald, D. M. (2010) Angiopoietin-2-driven vascular remodeling in airway inflammation. Am. J. Pathol. 177, 3233-3243
10. Lamalice, L., Le Boeuf, F. and Huot, J. (2007) Endothelial cell migration during angiogenesis. Circ. Res. 100, 782-794 (Pubitemid 46555683)
11. Sluimer, J. C. and Daemen, M. J. (2009) Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis. J. Pathol. 218, 7-29
12. Hoeben, A., Landuyt, B., Highley, M. S., Wildiers, H., Van Oosterom, A. T. and De Bruijn, E. A. (2004) Vascular endothelial growth factor and angiogenesis. Pharmacol. Rev. 56, 549-580 (Pubitemid 39658463)
13. Shen, J. and DiCorleto, P. E. (2008) ADP stimulates human endothelial cell migration via P2Y1 nucleotide receptor-mediated mitogen-activated protein kinase pathways. Circ. Res. 102, 448-456 (Pubitemid 351651109)
14. Beecken, W. D., Engl, T., Ringel, E. M., Camphausen, K., Michaelis, M., Jonas, D., Folkman, J., Shing, Y. and Blaheta, R. A. (2006) An endogenous inhibitor of angiogenesis derived from a transitional cell carcinoma: clipped β2-glycoprotein-I. Ann. Surg. Oncol. 13, 1241-1251 (Pubitemid 44440426)
15. 2 glycoprotein I. J. Autoimmun. 35, 232-240
16. 2-glycoprotein 1 is an inhibitor of angiogenesis. Am. J. Pathol. 171, 1659-1669
17. 2-Glycoprotein I inhibits vascular endothelial growth factor and basic fibroblast growth factor induced angiogenesis through its amino terminal domain. J. Thromb. Haemost. 6, 1215-1223
18. Sarkar, F. H., Li, Y., Wang, Z. and Kong, D. (2008) NF-κB signaling pathway and its therapeutic implications in human diseases. Int. Rev. Immunol. 27, 293-319
19. Tabruyn, S. P. and Griffioen, A. W. (2007) A new role for NF-κB in angiogenesis inhibition. Cell Death Differ. 14, 1393-1397 (Pubitemid 47086727)
20. Tabruyn, S. P. and Griffioen, A. W. (2008) NF-κB: a new player in angiostatic therapy. Angiogenesis 11, 101-106
21. Davis, M. E., Grumbach, I. M., Fukai, T., Cutchins, A. and Harrison, D. G. (2004) Shear stress regulates endothelial nitric-oxide synthase promoter activity through nuclear factor κB binding. J. Biol. Chem. 279, 163-168 (Pubitemid 38044811)
22. Tabruyn, S. P., Memet, S., Ave, P., Verhaeghe, C., Mayo, K. H., Struman, I., Martial, J. A. and Griffioen, A. W. (2009) NF-κB activation in endothelial cells is critical for the activity of angiostatic agents. Mol. Cancer Ther. 8, 2645-2654
23. Wang, S., Aurora, A. B., Johnson, B. A., Qi, X., McAnally, J., Hill, J. A., Richardson, J. A., Bassel-Duby, R. and Olson, E. N. (2008) The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev. Cell 15, 261-271
24. Zhu, W., Saddar, S., Seetharam, D., Chambliss, K. L., Longoria, C., Silver, D. L., Yuhanna, I. S., Shaul, P. W. and Mineo, C. (2008) The scavenger receptor class B type I adaptor protein PDZK1 maintains endothelial monolayer integrity. Circ. Res. 102, 480-487 (Pubitemid 351651102)
25. Bu, P., Gao, L., Zhuang, J., Feng, J., Yang, D. and Yan, X. (2006) Anti-CD146 monoclonal antibody AA98 inhibits angiogenesis via suppression of nuclear factor-κB activation. Mol. Cancer Ther. 5, 2872-2878 (Pubitemid 44849014)
26. Hamuro, M., Polan, J., Natarajan, M. and Mohan, S. (2002) High glucose induced nuclear factor κB mediated inhibition of endothelial cell migration. Atherosclerosis 162, 277-287 (Pubitemid 34460700)
27. Lin, C. I., Chen, C. N., Huang, M. T., Lee, S. J., Lin, C. H., Chang, C. C. and Lee, H. (2008) Lysophosphatidic acid upregulates vascular endothelial growth factor-C and tube formation in human endothelial cells through LPA(1/3), COX-2, and NF-κB activation and EGFR transactivation-dependent mechanisms. Cell. Signalling 20, 1804-1814
28. Hayden, M. S. and Ghosh, S. (2008) Shared principles in NF-κB signaling. Cell 132, 344-362
29. Perkins, N. D. (2007) Integrating cell-signalling pathways with NF-κB and IKK function. Nat. Rev. Mol. Cell Biol. 8, 49-62
30. Wang, T. M., Chen, C. J., Lee, T. S., Chao, H. Y., Wu, W. H., Hsieh, S. C., Sheu, H. H. and Chiang, A. N. (2011) Docosahexaenoic acid attenuates VCAM-1 expression and NF-κB activation in TNF-α-treated human aortic endothelial cells. J. Nutr. Biochem. 22, 187-194
31. Grumbach, I. M., Chen, W., Mertens, S. A. and Harrison, D. G. (2005) A negative feedback mechanism involving nitric oxide and nuclear factor κ-B modulates endothelial nitric oxide synthase transcription. J. Mol. Cell. Cardiol. 39, 595-603 (Pubitemid 41331048)
32. Hayashi, T., Yano, K., Matsui-Hirai, H., Yokoo, H., Hattori, Y. and Iguchi, A. (2008) Nitric oxide and endothelial cellular senescence. Pharmacol. Ther. 120, 333-339
33. Podesser, B. K. and Hallstrom, S. (2007) Nitric oxide homeostasis as a target for drug additives to cardioplegia. Br. J. Pharmacol. 151, 930-940 (Pubitemid 47195519)
34. Borniquel, S., Garcia-Quintans, N., Valle, I., Olmos, Y., Wild, B., Martinez-Granero, F., Soria, E., Lamas, S. and Monsalve, M. (2010) Inactivation of Foxo3a and subsequent downregulation of PGC-1α mediate nitric oxide-induced endothelial cell migration. Mol. Cell. Biol. 30, 4035-4044
35. Bulotta, S., Ierardi, M. V., Maiuolo, J., Cattaneo, M. G., Cerullo, A., Vicentini, L. M. and Borgese, N. (2009) Basal nitric oxide release attenuates cell migration of HeLa and endothelial cells. Biochem. Biophys. Res. Commun. 386, 744-749
36. Genis, L., Gonzalo, P., Tutor, A. S., Galvez, B. G., Martinez-Ruiz, A., Zaragoza, C., Lamas, S., Tryggvason, K., Apte, S. S. and Arroyo, A. G. (2007) Functional interplay between endothelial nitric oxide synthase and membrane type 1 matrix metalloproteinase in migrating endothelial cells. Blood 110, 2916-2923 (Pubitemid 350006945)
37. 2-glycoprotein I protects J774A.1 macrophages and human coronary artery smooth muscle cells against apoptosis. J. Cell. Biochem. 94, 485-496
38. 2-glycoprotein I) to lipoproteins. Prostaglandins Other Lipid Mediators 57, 351-359
39. 2-glycoprotein I in thrombotic disorders and in inflammation. Lupus 15, 87-93
40. Castro, A., Lazaro, I., Selva, D. M., Cespedes, E., Girona, J., NuriaPlana, Guardiola, M., Cabre, A., Simo, R. and Masana, L. (2010) APOH is increased in the plasma and liver of type 2 diabetic patients with metabolic syndrome. Atherosclerosis 209, 201-205
41. 2-glycoprotein I plasma levels and the risk of myocardial infarction in older men. Blood 114, 3656-3661
42. Lin, K. Y., Pan, J. P., Yang, D. L., Huang, K. T., Chang, M. S., Ding, P. Y. and Chiang, A. N. (2001) Evidence for inhibition of low density lipoprotein oxidation and cholesterol accumulation by apolipoprotein H (β2-glycoprotein I). Life Sci. 69, 707-719 (Pubitemid 32673629)
43. 2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress-induced cell injury. Blood 116, 1961-1970
44. 2-glycoprotein-I inhibits endothelial cell growth by down-regulating cyclin A, B and D1 and up-regulating p21 and p27. Cancer Lett. 296, 160-167
45. 2- glycoprotein I binds angiostatin 4.5 (plasminogen kringle 1-5) and attenuates its antiangiogenic property. Blood 114, 2553-2559
46. Golovine, K., Uzzo, R. G., Makhov, P., Crispen, P. L., Kunkle, D. and Kolenko, V. M. (2008) Depletion of intracellular zinc increases expression of tumorigenic cytokines VEGF, IL-6 and IL-8 in prostate cancer cells via NF-κB-dependent pathway. Prostate 68, 1443-1449
47. Tobe, M., Isobe, Y., Tomizawa, H., Nagasaki, T., Takahashi, H. and Hayashi, H. (2003) A novel structural class of potent inhibitors of NF-κB activation: structure-activity relationships and biological effects of 6-aminoquinazoline derivatives. Bioorg. Med. Chem. 11, 3869-3878 (Pubitemid 36970113)
48. Daniel, K. G., Chen, D., Orlu, S., Cui, Q. C., Miller, F. R. and Dou, Q. P. (2005) Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells. Breast Cancer Res. 7, R897-R908
49. Schreck, R., Meier, B., Mannel, D. N., Droge, W. and Baeuerle, P. A. (1992) Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J. Exp. Med. 175, 1181-1194
50. Pacher, P., Beckman, J. S. and Liaudet, L. (2007) Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87, 315-424 (Pubitemid 46217686)